Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Spectrum Health First in Michigan to Implant Neurostimulator for Hard-to-Treat Epilepsy Patients

12.06.2014

Spectrum Health is the first health system in Michigan and among the first in the nation to successfully implant a recently FDA-approved device that uses electric stimulation of the brain to treat adult epilepsy patients whose seizures have not responded to medication.

The NeuroPace® Responsive Neurostimulation (RNS®) System is an implantable therapeutic device designed to detect abnormal electrical activity in the brain and respond by delivering imperceptible electrical stimulation to normalize brain activity before an individual experiences seizures.

The procedure was successfully carried out May 6 in a six-hour surgery at Spectrum Health Butterworth Hospital in Grand Rapids. The first patient, Amy Owen, 44, of Marshall, Mich., is recovering at home. A second patient, Kelly Cromer, 43, of Dowagiac, Mich., underwent surgery May 14 and also is recovering at home. (Links to surgery and interview footage of Kelly Cromer).

The operations were carried out by a team led by Kost Elisevich, MD, PhD, neurosurgeon, co-chair department of clinical neurosciences, chief, division of neurosurgery, Spectrum Health Medical Group. Dr. Elisevich was assisted in the May 6 surgery by neurosurgeon Sanjay Patra, MD, and in the May 14 procedure by neurosurgeon Artur Szymczak, MD.

The surgery places the NeuroPace RNS Neurostimulator, essentially a battery powered microprocessor, into a cavity created in the patient’s cranium. This device is connected to electrodes implanted in the brain at the site where seizures are believed to originate. The May 6 procedure was the first of its kind in the state of Michigan and was among the first 20 such procedures in the nation. Spectrum Health is one of only 10 Level 4 epilepsy centers currently approved to conduct the surgery.  

"Spectrum Health's neuroscience program continues to expand its clinical and surgical offerings, providing patients highly specialized care in their region and exceeding important national quality standards," said Kevin Splaine, president, Spectrum Health Hospitals, Grand Rapids. “Our epilepsy team is specially designated for its superior medical and surgical care.”

Owen was admitted to the Epilepsy Monitoring Unit at Spectrum Health Butterworth Hospital in late April. In an initial procedure, Dr. Elisevich surgically implanted electrodes into her brain to initiate the monitoring of seizures with a continuous inpatient video electroencephalographic (vEEG).

This mapping pinpointed the origin of Owen's seizures in the left temporal lobe, enabling physicians to target the optimal location for placement of the NeuroPace RNS Neurostimulator, a titanium microprocessor measuring about one by two inches, which is connected to electrodes implanted at the site of seizure origin. The monitoring also indicated that Owen was undergoing near continuous seizure activity while she slept.

While her doctors consider the operation to be a success, they caution that the work of monitoring and interrupting seizure activity in Owen's brain is only just beginning.

"Seizure activity can often be temporarily disrupted by the placing of electrodes during surgery," Dr. Elisevich said. "The next phase is to wait for her brain to start misbehaving again so that the computer can be programmed to interrupt the dysfunctional signaling."

During this phase of the process, the patient uses an electronic wand to download data from the device on a daily basis. This information enables her medical team to track her seizure activity and disrupt it by programming the device to deliver short, imperceptible electrical pulses to the brain through the implanted electrodes.

"This information will enable us to identify a distinct pattern of seizure onset, which we can break down by frequency, amplitude and a number of other factors," said Owen's neurologist, Brien Smith, MD, co-chair, department of clinical neurosciences, chief, division of neurology, Spectrum Health Medical Group. "This makes us very optimistic that we can alter abnormal brain activity and significantly reduce seizure initiation and spread."

The RNS System is designed for use in combination with other therapies in reducing the frequency of seizures in individuals 18 years of age or older. It is indicated for use in patients with partial onset seizures – seizures that originate and remain in a limited area of the brain. To be eligible for the procedure, patients must have frequent and disabling seizures (motor partial seizures, complex partial seizures and/or secondarily generalized seizures), whose origin is limited to two or fewer locations in the brain.

The U.S. Food and Drug Administration (FDA) granted premarket approval for the RNS System on November 14, 2013. While employed at Henry Ford Health System, Drs. Elisevich and Smith were one of the first clinical teams in the nation to participate in clinical trials using the RNS System.

Epilepsy is the third most common neurological disorder in the United States after Alzheimer's disease and stroke, affecting 2.2 million Americans, according to the Centers for Disease Control and Prevention (CDC). Older adults are among the fastest-growing segments of the population for new cases of the disease.

Treatment with the RNS System is taking place in Level 4 epilepsy centers throughout the nation following site qualification and physician training. Spectrum Health is the first epilepsy program in West Michigan to receive a Level 4 designation by the National Association of Epilepsy Centers (NAEC). Level 4 centers have the professional expertise and facilities to provide the highest level of medical and surgical epilepsy evaluation and treatment for patients with epilepsy.

Spectrum Health is a not-for-profit health system, based in West Michigan, offering a full continuum of care through the Spectrum Health Hospital Group, which is comprised of 11 hospitals including Helen DeVos Children's Hospital; 170 ambulatory and service sites; 1,080 employed physicians and advanced practice providers including members of the Spectrum Health Medical Group; and Priority Health, a 575,000-member health plan. Spectrum Health is West Michigan's largest employer with 21,300 employees. The organization provided $250 million in community benefit during its 2013 fiscal year.

Daniel Fowler | Eurek Alert!
Further information:
http://www.spectrumhealth.org/body.cfm?id=677&limit_location=&limit_category=&action=detail&ref=945

Further reports about: Epilepsy Implant RNS activity electrodes microprocessor neurosurgeon procedure seizure

More articles from Medical Engineering:

nachricht New insight into the brain’s hidden depths: Jena scientists develop minimally-invasive endoscope
27.11.2018 | Leibniz-Institut für Photonische Technologien e. V.

nachricht New China and US studies back use of pulse oximeters for assessing blood pressure
21.11.2018 | University of British Columbia

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Data use draining your battery? Tiny device to speed up memory while also saving power

The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.

Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...

Im Focus: An energy-efficient way to stay warm: Sew high-tech heating patches to your clothes

Personal patches could reduce energy waste in buildings, Rutgers-led study says

What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...

Im Focus: Lethal combination: Drug cocktail turns off the juice to cancer cells

A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.

The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...

Im Focus: New Foldable Drone Flies through Narrow Holes in Rescue Missions

A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.

Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...

Im Focus: Topological material switched off and on for the first time

Key advance for future topological transistors

Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

ICTM Conference 2019: Digitization emerges as an engineering trend for turbomachinery construction

12.12.2018 | Event News

New Plastics Economy Investor Forum - Meeting Point for Innovations

10.12.2018 | Event News

EGU 2019 meeting: Media registration now open

06.12.2018 | Event News

 
Latest News

Data use draining your battery? Tiny device to speed up memory while also saving power

14.12.2018 | Power and Electrical Engineering

Tangled magnetic fields power cosmic particle accelerators

14.12.2018 | Physics and Astronomy

In search of missing worlds, Hubble finds a fast evaporating exoplanet

14.12.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>